BUZZ — AI prenatal screening firm Identifai Genetics shines in ASX debut
* Identifai Genetics makes ASX debut, with shares up as much as 20% at A$0.24 after the biotech raised A$10 million ($6.95 million) via an IPO priced at A$0.20 per share * Company is developing an AI-powered platform that screens unborn babies for certain inherited conditions using one blood sample from the mother * IP